Severity But Not Comorbidities Predicts Response to Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Naturalistic Study

@article{Victor2014SeverityBN,
  title={Severity But Not Comorbidities Predicts Response to Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Naturalistic Study},
  author={M. Victor and D. Rovaris and C. A. Salgado and K. Silva and R. G. Karam and E. Vitola and F. Picon and V. Contini and P. O. Guimar{\~a}es-da-Silva and Paula Blaya-Rocha and P. Belmonte-de-Abreu and L. A. Rohde and E. Grevet and Claiton H.D. Bau},
  journal={Journal of Clinical Psychopharmacology},
  year={2014},
  volume={34},
  pages={212–217}
}
  • M. Victor, D. Rovaris, +11 authors Claiton H.D. Bau
  • Published 2014
  • Medicine
  • Journal of Clinical Psychopharmacology
  • Abstract Although the identification of reliable predictors of methylphenidate response in adults with attention-deficit/hyperactivity disorder (ADHD) is necessary to guide treatment decisions, very few data exist on this issue. Here, we assessed the predictors of clinical response to immediate-release methylphenidate hydrochloride (IR-MPH) in a naturalistic setting by analyzing the influence of demographic factors, severity, and a wide range of comorbid psychiatric disorders. Two hundred fifty… CONTINUE READING
    13 Citations
    Persistence and remission of ADHD during adulthood: a 7-year clinical follow-up study.
    • 64
    • PDF
    Further replication of the synergistic interaction between LPHN3 and the NTAD gene cluster on ADHD and its clinical course throughout adulthood
    • 7
    • PDF
    ADHD and Anxiety: Clinical Significance and Treatment Implications
    • 22
    • PDF

    References

    SHOWING 1-10 OF 56 REFERENCES
    Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder
    • 152
    • Highly Influential
    • PDF
    Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.
    • J. Swanson, H. Kraemer, +21 authors M. Wu
    • Psychology, Medicine
    • Journal of the American Academy of Child and Adolescent Psychiatry
    • 2001
    • 873
    • PDF
    Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate
    • 38
    Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
    • R. Robison, F. Reimherr, +5 authors R. Strong
    • Medicine
    • Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
    • 2010
    • 13
    • Highly Influential
    Lack of gender effects on subtype outcomes in adults with attention–deficit/hyperactivity disorder
    • 81
    OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
    • 22
    • Highly Influential
    Late-onset ADHD in adults: milder, but still dysfunctional.
    • 64